Harm Reduction

Justin Trudeau tells UBC students he wants supervised injection sites across Canada

Liberal Party leader Justin Trudeau has reaffirmed his support for an expansion of supervised injection services across Canada. At the same event, the would-be prime minister also restated his belief that hard drugs should not be decriminalized. Trudeau was speaking in Vancouver at the University of British Columbia on March 4. A few members of […]

Justin Trudeau tells UBC students he wants supervised injection sites across Canada Read More »

Safe injection sites needed Canada-wide to fight hep B, C

The Canadian Coalition of Organizations Responding to Hepatitis B and C has issued a report card on Canada’s performance and found that resources are inconsistent across the country. Co-ordination appears particularly poor in Prince Edward Island, Nunavut and the Northwest Territories and prison inmates across the country are especially vulnerable, the group says in its

Safe injection sites needed Canada-wide to fight hep B, C Read More »

Apr-11

UN recommends made-in-BC strategy to reshape global AIDS response Secretary-General’s report calls for linkage of treatment and prevention Treatment as Prevention, the groundbreaking HIV treatment paradigm pioneered at the BC Centre for Excellence in HIV/AIDS (BC-CfE), has been endorsed by a recently released United Nations report. The report identifies Treatment as Prevention as a key

Apr-11 Read More »

HIV rates among injection drug users continue to drop

Harm reduction measures and anti-retroviral therapy are cutting down B.C.’s HIV infection rates among injection drug users, says a new report released Thursday by the Health Ministry. Provincial health officer Dr. Perry Kendall released a report revealing several factors associated with the drop in intravenous drug users catching HIV or hepatitis C. Among the factors

HIV rates among injection drug users continue to drop Read More »

HIV dropping among IV drug users due to harm reduction, says B.C.’s health officer

B.C.’s top doctor is pushing to keep harm reduction and anti-retroviral therapy as key health strategies after a new report showed rates of HIV infection among those who inject drugs continues to drop. Provincial health officer Dr. Perry Kendall released the report noting several reasons why intravenous drug users aren’t catching HIV or hepatitis C

HIV dropping among IV drug users due to harm reduction, says B.C.’s health officer Read More »

Mar-11

China chooses made-in-BC approach to combat HIV and AIDS worldwide World’s most populous nation embraces treatment as prevention The BC Centre for Excellence in HIV/AIDS (BC-CfE) hosted a Chinese delegation led by Dr. Zunyou Wu last year to share their expertise on the internationally recognized treatment as prevention strategy and collaborate on the development of

Mar-11 Read More »

July/August 2010

UNAIDS Treatment 2.0 based on made-in-B.C. “treatment as prevention” strategy A radical new approach to HIV treatment, dubbed “Treatment 2.0,” aims to dramatically increase testing andtreatment for HIV using the best available diagnostic tools and drugs, announced Michel Sidibé, executive director of the Joint United Nations Programme on HIV/AIDS (UNAIDS), at the XVIII International AIDS

July/August 2010 Read More »

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)